Related Experiment Videos
Essential fatty acids in Huntington's disease
Undurti N Das1, Krishna S Vaddadi
1UND Life Sciences, Walpole, Massachusetts 02081, USA. Undurti@hotmail.com
Nutrition (Burbank, Los Angeles County, Calif.)
|October 12, 2004
Summary
Essential fatty acids show promise in treating Huntington's disease, a neurodegenerative disorder. Supplementation improved survival and reduced neurological deficits in mouse models and patients.
Area of Science:
- Neurodegenerative diseases
- Genetics
- Molecular biology
Background:
- Huntington's disease is an inherited neurodegenerative disorder caused by a mutation in the Huntingtin gene, leading to toxic polyglutamine (polyQ) aggregation.
- PolyQ aggregates in neuronal nuclei disrupt gene transcription, histone deacetylase activity, and the ubiquitin-proteasome system, causing neurodegeneration.
Purpose of the Study:
- To investigate the therapeutic potential of essential fatty acids in Huntington's disease.
- To explore the mechanisms by which fatty acids may counteract polyQ toxicity.
Main Methods:
- Utilized transgenic R6/1 mice expressing a human Huntington's disease gene fragment.
- Administered essential fatty acids to mice and assessed neurological deficits and survival rates.
- Reviewed findings from a randomized, placebo-controlled study on highly unsaturated fatty acids in Huntington's disease patients.
Main Results:
- Essential fatty acid supplementation increased survival rates and decreased neurological deficits in R6/1 mice.
- Highly unsaturated fatty acids demonstrated benefits for patients with Huntington's disease.
- Fatty acids may inhibit polyQ aggregation, histone deacetylase, and/or activate the ubiquitin-proteasome system.
Conclusions:
- Essential fatty acids show significant therapeutic potential for Huntington's disease.
- Further research into fatty acid use for other neurodegenerative conditions is warranted.